Predicting short-term interruptions of antiretroviral therapy from summary adherence data: Development and test of a probability model.
Ontology highlight
ABSTRACT: Antiretroviral therapy (ART) for HIV is vulnerable to unplanned treatment interruptions-consecutively missed doses over a series of days-which can result in virologic rebound. Yet clinicians lack a simple, valid method for estimating the risk of interruptions. If the likelihood of ART interruption could be derived from a convenient-to-gather summary measure of medication adherence, it might be a valuable tool for both clinical decision-making and research. We constructed an a priori probability model of ART interruption based on average adherence and tested its predictions using data collected on 185 HIV-infected, treatment-naïve individuals over the first 90 days of ART in a prospective cohort study in Mbarara, Uganda. The outcome of interest was the presence or absence of a treatment gap
SUBMITTER: Harris RA
PROVIDER: S-EPMC5864044 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature
ACCESS DATA